Response to Comments: MolDX: Cystatin C Measurement

This notice (Policy A56177) documents the response to comments for MolDX: Cystatin C Measurement (DL37581). The public comment period was 2018-02-14 to 2018-03-31, the notice period was 2018-11-01 to 2018-12-16, and the LCD became final on 2018-12-17. The document is administrative and does not specify clinical coverage indications, limitations, documentation requirements, or frequency limits for cystatin C measurement.